» Articles » PMID: 19870655

DEMONSTRATION OF PASSIVE IMMUNITY IN EXPERIMENTAL MONKEY MALARIA

Overview
Journal J Exp Med
Date 2009 Oct 30
PMID 19870655
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

A Plasmodium knowlesi infection in rhesus monkeys is almost invariably fatal. This infection, however, may be made chronic by the early administration of antimalarial drugs. The animals then will harbor a chronic infection for an indefinite period. The serum taken from monkeys with chronic infection and injected into those suffering from an acute attack was found to have a definite depressing effect upon the course of the experimental disease. In some instances death was prevented and the acute infection changed into a chronic form; in others, the course of the experimental disease was prolonged. In a similar manner the serum from monkeys harboring a chronic Plasmodium inui infection, when injected into monkeys suffering from an acute attack due to this parasite, was found to be effective in reducing the intensity of the primary infection. The data presented indicate that protective antibodies are produced in the serum of monkeys during experimental malaria infection.

Citing Articles

The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for .

Takashima E, Otsuki H, Morita M, Ito D, Nagaoka H, Yuguchi T Biomolecules. 2024; 14(1).

PMID: 38254700 PMC: 10813614. DOI: 10.3390/biom14010100.


Mouse Models for Unravelling Immunology of Blood Stage Malaria.

Olatunde A, Cornwall D, Roedel M, Lamb T Vaccines (Basel). 2022; 10(9).

PMID: 36146602 PMC: 9501382. DOI: 10.3390/vaccines10091525.


Framework for Characterizing Longitudinal Antibody Response in Children After Infection.

Rogier E, Nace D, Dimbu P, Wakeman B, Pohl J, Beeson J Front Immunol. 2021; 12:617951.

PMID: 33737926 PMC: 7960919. DOI: 10.3389/fimmu.2021.617951.


Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells.

Akter J, Khoury D, Aogo R, Lansink L, SheelaNair A, Thomas B PLoS Pathog. 2019; 15(2):e1007599.

PMID: 30811498 PMC: 6411214. DOI: 10.1371/journal.ppat.1007599.


Evaluating antidisease immunity to malaria and implications for vaccine design.

Ademolue T, Awandare G Immunology. 2017; 153(4):423-434.

PMID: 29211303 PMC: 5838420. DOI: 10.1111/imm.12877.